HHS Reports Cost-Savings for Extending Anti-Rejection Medication Coverage

Statement from Honor the Gift on the new HHS report outlining the benefits of extending immunosuppressive medication coverage under Medicare

Today is a significant milestone for kidney transplant recipients, their families, donors, and donor families. The Department of Health and Human Services’ Office of the Assistant Secretary for Planning and Evaluation (ASPE) released an analysis that estimates extending coverage for immunosuppressive medications for kidney transplant patients on Medicare would save $73 million over 10 years.  This is monumental news for the kidney and transplant community. ASPE has confirmed through this analysis what we’ve long known to be true—extending Medicare coverage for immunosuppressive medications would prolong the viability of transplanted kidneys while also saving Medicare money.

Congress, it’s time to introduce the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act—a bipartisan solution that would honor the gift of kidney donation by extending this essential medication coverage, permanently.